SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-023462
Filing Date
2023-05-22
Accepted
2023-05-22 16:29:36
Documents
92
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q celu-20230331.htm   iXBRL 10-Q 3348539
2 EX-31.1 celu-ex31_1.htm EX-31.1 21381
3 EX-31.2 celu-ex31_2.htm EX-31.2 21369
4 EX-32.1 celu-ex32_1.htm EX-32.1 13818
5 EX-32.2 celu-ex32_2.htm EX-32.2 13523
  Complete submission text file 0000950170-23-023462.txt   15752132

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20230331_lab.xml EX-101.LAB 778680
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20230331_pre.xml EX-101.PRE 641972
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT celu-20230331_cal.xml EX-101.CAL 64835
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20230331.xsd EX-101.SCH 113075
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20230331_def.xml EX-101.DEF 503821
86 EXTRACTED XBRL INSTANCE DOCUMENT celu-20230331_htm.xml XML 3562248
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 23944868
SIC: 2834 Pharmaceutical Preparations